Dow Chemical Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$185M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$126M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$65.8M |
| 4 |
iShares Preferred and Income Securities ETF
PFF
|
+$49.6M |
| 5 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$17.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 6.51% |
| 2 | Materials | 4.9% |
| 3 | Technology | 2.58% |
| 4 | Healthcare | 0% |
Similar funds
Dow Chemical Company's Q2 2021 Portfolio in Review
As of Q2 2021, Dow Chemical Company held 11 positions worth $891M, up 114% from $416M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Dow Chemical Company deployed $453M of net new capital in Q2 2021, opening 5 new positions and adding to 1 existing holding. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,400,000 shares worth $188M.
By sector, the portfolio is most concentrated in Industrials at 6.5% of assets, down from 12% a quarter earlier, followed by Materials and Technology.
On the sell side, the most notable exit was Inari Medical, Inc. Common Stock, an estimated $1.67M sold.
- Dow Chemical Company's largest Q2 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,400,000 shares worth $188M.
- Dow Chemical Company added most to iShares Core US Aggregate Bond ETF in Q2 2021, an estimated $10.9M increase.
- Dow Chemical Company fully exited Inari Medical, Inc. Common Stock in Q2 2021, selling an estimated $1.67M.
- Dow Chemical Company's ten largest holdings make up 100% of its $891M portfolio in Q2 2021.
- Dow Chemical Company opened 5 new positions and closed 1 in Q2 2021.
- Dow Chemical Company's portfolio value rose 114% quarter-over-quarter to $891M.
Based on Dow Chemical Company's 13F filing for Q2 2021, filed 12 Aug 2021.